Adding another epilepsy medicine to your current treatment can help you better control your partial-onset seizures. That is why you and your neurologist have added Vimpat—a medicine that treats partial-onset seizures.
In almost 10 years of studies, the proven safety profile of Vimpat has shown:
- Little effect on weight
- Little effect on memory
- It can be taken with most other epilepsy medicines
Sign up now to take up to $30 off each of your next 12 co-pays
for Vimpat
Adding Vimpat can help make seizure control possible. Here are some important things you should know about adding Vimpat to your treatment plan:
- Always take Vimpat as instructed by your doctor.
- Tell your neurologist if you still have frequent seizures or any side effects.
- You may begin to notice the benefits of Vimpat in a few weeks. Keep taking it even if you don’t see a change right away, because for some people it may take longer.
- Your neurologist will work with you to find the dose of Vimpat that works best for you.
Sign up now to take up to $30 off each of your next 12 co-pays
for Vimpat
For over 20 years, UCB has been dedicated to creating effective epilepsy treatments to help improve the lives of people living with epilepsy. Now, our dedication extends to helping people afford the epilepsy medicines they need and engaging the epilepsy community.
Sign up now to take up to $30 off each of your next 12 co-pays
for Vimpat
Indication
Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.
Important Safety Information
Vimpat is generally well-tolerated, but may not be for everyone. Ask your healthcare provider if Vimpat is right for you.
Warnings and Precautions
Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Do not stop taking Vimpat without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems.
Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.
Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.
Vimpat is classified as a federally controlled substance (C-V) due to a low potential for abuse. Keep your Vimpat in a safe place and do not give it to anyone else.
In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.
Vimpat oral solution contains aspartame, a source of phenylalanine.
Common Adverse Reactions
The most common side effects with Vimpat are dizziness, headache, nausea, and double vision. To report Suspected Adverse Reactions, contact UCB, Inc. at 866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.